Basilea Pharmaceutica AG Allschwil Eulerpool News

Basilea Pharmaceutica AG Allschwil Stock News

Basilea Pharmaceutica AG Allschwil is being monitored by journalists and investors worldwide. We gather the latest Basilea Pharmaceutica AG Allschwil news here.

• September 24 ·

  Yahoo
  Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis
• September 19 ·

  Yahoo
  Basilea enters into agreement with BARDA to develop novel antifungals and antibacterials and receives initial funding
• September 6 ·

  Yahoo
  Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 25 million sales milestone payment to Basilea
• August 28 ·

  Thefly.com
  Basilea price target raised to CHF 95 from CHF 94 at H.C. Wainwright
• August 27 ·

  Yahoo
  European Commission Decision to approve the pediatric use of antifungal Cresemba® (isavuconazole) and extension of market exclusivity triggers CHF 10 million milestone payment to Basilea
• August 21 ·

  Yahoo
  Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
• August 20 ·

  Yahoo
  Recent Price Trend in Basilea Pharmaceutica (BPMUF) is Your Friend, Here's Why
• August 13 ·

  SeekingAlpha
  Basilea Pharmaceutica AG (BPMUF) Q2 2024 Earnings Call Transcript
• August 13 ·

  Seeking Alpha
  Basilea Pharmaceutica GAAP EPS of CHF 1.61, revenue of CHF 76.3M; raises FY24 outlook
• August 13 ·

  Yahoo
  Basilea reports strong 2024 half-year results and significantly increases full-year revenue and profit guidance